Hepatitis/MASH

The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.

Latest News

Hepatitis D blood sample | Image Credit: © Innovative Creation - stock.adobe.com
Hepatitis D Reclassified as Carcinogenic, According to WHO

August 4th 2025

WHO reclassifies hepatitis D as carcinogenic, urging global action to combat viral hepatitis and reduce liver cancer risk.

Updated European MASLD Guidelines Review Prevention, Screening, and Treatments
Updated European MASLD Guidelines Review Prevention, Screening, and Treatments

August 1st 2025

Liver pain: abdominal discomfort, hepatic strain, organ distress, bile issue, jaundice symptom, inflammation, detox failure, cirrhosis sign, liver infection, digestive disturbance.
Remnant Cholesterol, Independent of LDL-C, Serves as Predictor of MASLD

July 24th 2025

DNA structure and HIV-infected
IAS 2025: Patients With HIV Grapple With Healthy Aging, Reducing CVD Risk

July 21st 2025

Video Interviews

More News